Bhadra Pharma Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 2.81 M
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.70 M
- Revenue Growth 66.61%
- Profit Growth -96.00%
- Ebitda -759.85%
- Net Worth -0.45%
- Total Assets 0.75%
About Bhadra Pharma Care
Bhadra Pharma Care Limited (BPCL) is a Public Limited Indian Non-Government Company incorporated in India on 21 June 1994 and has a history of 30 years and eight months. Its registered office is in Dahod, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.81 M.
The company has closed loans amounting to ₹1.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aashish Shah, Vinitkumar Jain, and Pankajkumar Shah serve as directors at the Company.
Company Details
- Location
Dahod, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1994PLC022300
- Company No.
022300
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jun 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Bhadra Pharma Care?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aashish Shah  | Director | 21-Jun-1994 | Current |
| Vinitkumar Jain | Director | 21-Jun-1994 | Current |
| Pankajkumar Shah | Director | 31-Dec-2002 | Current |
Financial Performance of Bhadra Pharma Care.
Bhadra Pharma Care Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 66.61% increase. The company also saw a substantial fall in profitability, with a 96% decrease in profit. The company's net worth dipped by a decrease of 0.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhadra Pharma Care?
Unlock access to Bhadra Pharma Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹0.17 Cr
Charges Breakdown by Lending Institutions
- The Dahod Urban Co-Op Bank Ltd : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jan 1995 | The Dahod Urban Co-Op Bank Ltd | ₹1.70 M | Satisfied |
How Many Employees Work at Bhadra Pharma Care?
Unlock and access historical data on people associated with Bhadra Pharma Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhadra Pharma Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhadra Pharma Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.